For the most part, developing new medical technologies is a huge benefit to people. Take for instance the smart pill that the U.S. Food and Drug Administration (FDA) just approved, which is meant to monitor if patients are sticking to their medication schedule. While incredibly useful, it could also allow entities like the U.S. government to spy on its citizens even more intrusively than it does now.
No one likes to be spied on and yet this is exactly what concerned privacy groups are saying could happen with the digital pill that the FDA just approved for use. Called the Abilify MyCite, the pill comes with sensors that basically indicate if patients just took their medication, Futurism reports.
Abilify is a drug used to treat neurological conditions such as schizophrenia and bipolar disorders. The sensor is embedded in the pill, where it will send out a signal once it comes in contact with the stomach. This signal will be picked up by a patch on the patient’s left rib cage, which will then notify the monitoring personnel via the accompanying app.
The information that the sensors can send out can include the dosage, the exact time when the pill was taken, and even what the patient was doing at the time. Because of how intrusive the data mining process appears, groups concerned about potential abuses are speaking out. They are especially worried about potential punitive actions against patients who are committing what’s called nonadherence.
Basically, nonadherence or noncompliance refers to patients not taking their medication as they are supposed to. This leads to patients getting sicker, which then leads to higher medical costs due to the increased medical attention that they need. Apparently, this particular trend costs $100 billion a year, the New York Times reports.
There’s also the concern of medical professionals that a smart pill could lead to a feeling of coercion on the part of the patients. Subjects could feel pressured to take their medication because their doctors are monitoring them.


Morgan Stanley Names Top AI Security and Data Center Stocks for 2026
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence
MongoDB Q1 FY2027 Earnings Beat Expectations, Raises Full-Year Outlook
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
EU Antitrust Probe Could Lead to Massive Google Fine Under DMA Rules
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Elon Musk Explores Possible Tesla-SpaceX Merger Amid Growing AI Investments
Huawei Chip Breakthrough Sparks Rally in Chinese Semiconductor Stocks
Samsung to Invest $1.5 Billion in Vietnam Semiconductor Testing Plant by 2027 



